A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib.
Estabragh
Zahra Raisi
ZR
Department of Haematology, University of Liverpool, Liverpool, UK.
Knight
Katy
K
Watmough
Sarah J
SJ
Lane
Steven
S
Vinjamuri
Sobhan
S
Hart
George
G
Clark
Richard E
RE
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides; D003430:Cross-Sectional Studies; D004452:Echocardiography; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate